Efter ett par tuffa år med kraftiga nedskärningar från regionerna syns nu tecken på en vändning för Dedicare.
Sweden still affected by cautious hiring policy Positive development in UK Normalisation before next growth phase? Q4: Net sales -7% y-o-y,...
Norway and Denmark are steaming ahead... ...more than offsetting the weaker Sweden Profitability coming down from a high base Q3: 13% organ...
• Two large regions in Sweden restrict staffing... • .
Weakness for nurses segment in Sweden... ...more than offset by other regions/segments A strong start to the year Q1: 22% organic sales gro...
Another impressive quarter in Norway Denmark is also gaining momentum Growth initiatives hurt profitability in Q4 Q4: Sales growth of 41% y...
Acquires Templars Medical Agency Ltd. Sees it as a platform to build from in UK and Ireland Dedicare’s vision is to become a leading playe...
43% sales growth y-o-y, 37% organic We raise ’23e sales & EBIT estimates by 6% and 10% New fair value range of SEK 89-116 (82-113) Q2: Adj.
Q2 report due on 15 July Dedicare is taking market share in a growing market New value range of SEK 82-113 Higher-than-usual need for healt...
~12% sales growth last 5Y 28% sales growth and above-target EBIT margin in ’22e Fair value range of SEK 72-114, 5x-8x ’22e EV/EBIT Strong g...
